Cullen/Frost Bankers’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
MBI
CGI
Cullen/Frost Bankers's IDXX Position: Q2 2026 in Review
Cullen/Frost Bankers reduced its Idexx Laboratories (IDXX) stake by 2.1% in Q2 2026, selling an estimated $44.3K and leaving 3,675 shares worth $1.93M. The position accounts for 0.02% of the portfolio, ranked #280.
Cullen/Frost Bankers first reported a position in IDXX in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.47M in Q4 2025. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Cullen/Frost Bankers held 3,675 shares of Idexx Laboratories worth $1.93M as of Q2 2026.
- Cullen/Frost Bankers sold 79 Idexx Laboratories shares in Q2 2026, an estimated $44.3K.
- Idexx Laboratories made up 0.02% of Cullen/Frost Bankers's portfolio in Q2 2026, its #280 holding.
- Cullen/Frost Bankers first reported a position in Idexx Laboratories in Q4 2019 and has held it in 26 quarters since.
- Cullen/Frost Bankers's Idexx Laboratories position peaked at $2.47M in Q4 2025.
- 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.